Primecap Management CO Bio N Tech Se Transaction History

Primecap Management CO

$126 Billion
Q3 2025

A detailed history of Primecap Management CO transactions in Bio N Tech Se stock. As of the latest transaction made, Primecap Management CO holds 3,870,766 shares of BNTX stock, worth $399 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

3,870,766

Previous 4,001,466 3.27%

Holding current value

$399 Million

Previous $426 Million 10.4%

% of portfolio

0.3%

Previous 0.35%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$96.22 - $115.31 $12.6 Million - $15.1 Million	-130,700 Reduced 3.27%	3,870,766 $382 Million
Q2 2025 Aug 11, 2025	SELL	$86.65 - $120.54 $3.9 Million - $5.42 Million	-44,959 Reduced 1.11%	4,001,466 $426 Million
Q1 2025 May 09, 2025	SELL	$91.06 - $126.88 $22.7 Million - $31.6 Million	-249,392 Reduced 5.81%	4,046,425 $368 Million
Q4 2024 Feb 10, 2025	SELL	$99.72 - $122.68 $22 Million - $27.1 Million	-220,701 Reduced 4.89%	4,295,817 $490 Million
Q3 2024 Nov 08, 2024	SELL	$78.36 - $124.66 $21.4 Million - $34 Million	-273,000 Reduced 5.7%	4,516,518 $536 Million

Q2 2024 Aug 09, 2024	SELL	$80.36 - $102.87 $1.48 Million - $1.89 Million	-18,400 Reduced 0.38%	4,789,518 $385 Million
Q1 2024 May 13, 2024	BUY	$88.96 - $112.35 $3.96 Million - $5 Million	44,465 Added 0.93%	4,807,918 $444 Million
Q4 2023 Feb 09, 2024	BUY	$90.91 - $112.75 $12 Million - $14.8 Million	131,490 Added 2.84%	4,763,453 $503 Million
Q3 2023 Nov 13, 2023	SELL	$98.5 - $125.08 $2.75 Million - $3.49 Million	-27,890 Reduced 0.6%	4,631,963 $503 Million
Q2 2023 Aug 11, 2023	BUY	$102.58 - $129.66 $8.78 Million - $11.1 Million	85,590 Added 1.87%	4,659,853 $503 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $49.2 Million - $61.6 Million	401,097 Added 9.61%	4,574,263 $570 Million
Q4 2022 Feb 13, 2023	SELL	$118.43 - $186.05 $2.51 Million - $3.95 Million	-21,222 Reduced 0.51%	4,173,166 $627 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $882,061 - $1.27 Million	-6,910 Reduced 0.16%	4,194,388 $566 Million
Q2 2022 Aug 11, 2022	SELL	$123.25 - $186.24 $5.02 Million - $7.59 Million	-40,770 Reduced 0.96%	4,201,298 $626 Million
Q1 2022 May 11, 2022	BUY	$126.25 - $231.85 $6.94 Million - $12.7 Million	54,950 Added 1.31%	4,242,068 $724 Million
Q4 2021 Feb 11, 2022	SELL	$216.64 - $362.52 $20.8 Million - $34.9 Million	-96,240 Reduced 2.25%	4,187,118 $1.08 Billion
Q3 2021 Nov 12, 2021	SELL	$205.93 - $447.23 $57.1 Million - $124 Million	-277,400 Reduced 6.08%	4,283,358 $1.17 Billion
Q2 2021 Aug 10, 2021	SELL	$113.32 - $241.49 $29.6 Million - $63 Million	-260,960 Reduced 5.41%	4,560,758 $1.02 Billion
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $16.6 Million - $23.1 Million	193,521 Added 4.18%	4,821,718 $526 Million
Q4 2020 Feb 08, 2021	BUY	$72.71 - $129.54 $36.5 Million - $65.1 Million	502,599 Added 12.18%	4,628,197 $377 Million
Q3 2020 Nov 13, 2020	BUY	$57.81 - $104.17 $78.2 Million - $141 Million	1,352,806 Added 48.79%	4,125,598 $286 Million
Q2 2020 Aug 13, 2020	BUY	$38.58 - $66.74 $6.2 Million - $10.7 Million	160,675 Added 6.15%	2,772,792 $185 Million
Q1 2020 May 14, 2020	BUY	$28.55 - $92.0 $13.8 Million - $44.5 Million	483,935 Added 22.74%	2,612,117 $153 Million
Q4 2019 Feb 14, 2020	BUY	$12.75 - $36.91 $27.1 Million - $78.6 Million	2,128,182 New	2,128,182 $72.1 Million

Others Institutions Holding BNTX

# of Institutions

321

Shares Held

43.6M

Call Options Held

1.17M

Put Options Held

1.38M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Bio N Tech Se Transaction History